BAXTER HOLDING BV

It is an antitumoral agent used to treat breast cancer (in patients at risk of heart problems), ovarian cancer, and multiple myeloma (in combination with bortezomib). It is also used to improve Kaposi's sarcoma by reducing its size and symptoms.

Dosage form: solution for infusion, concentrate

ATC: L01DB01

It is an antitumoral agent used for the treatment of breast cancer (in patients at risk of heart problems), ovarian cancer, and multiple myeloma (in combination with bortezomib). It is also used to improve the symptoms of Kaposi's sarcoma.

Dosage form: concentrate for dispersion for infusion

ATC: L01DB01

It is used in adults and children from 3 months of age onwards to treat infections of the skin or subcutaneous tissues caused by certain bacteria.

Dosage form: powder for concentrate for infusion solution

ATC: J01XA04

It is an anticancer drug used in adults for the treatment of locally advanced or metastatic breast cancer (when other therapies have not been effective) and for advanced or metastatic liposarcoma (when a previous therapy has not been effective).

Dosage form: solution for injection

ATC: L01XX41

It is used for the short-term treatment of fever and to relieve moderate pain, especially after surgery.

Dosage form: solution for infusion

ATC: N02BE01

This medicine is a general anesthetic used to induce and maintain deep sleep during surgical operations or medical procedures. It can also be used for the sedation of adults and children.

Dosage form: emulsion, injectable

ATC: N01AX10

It is used to induce and maintain general anesthesia in adults and children (over 1 month for the 10 mg/ml version and over 3 years for the 20 mg/ml version) and for sedation during surgical or diagnostic procedures. It can also be used to sedate patients over 16 years of age in intensive care undergoing mechanical ventilation.

Dosage form: emulsion for injection/infusion

ATC: N01AX10